Analysts are changing their tune on Solventum as 2025 comes to a close, as analysts at BTIG upgrade the company to “buy” in the final month of the year. Solventum has spent the last year routinely ...

Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million for wound care specialist Acera Surgical in its first major acquisition. At the same time, Solventum announced ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's Solventum's first big ...

Healthcare company Solventum agreed to acquire Acera Surgical for $725 million in cash, further expanding into the regenerative wound care market. The agreement also calls for up to $125 million in ...

Solventum (SOLV) 3M’s (MMM) healthcare spinoff, on Thursday announced an agreement to acquire Acera Surgical, a privately owned wound care company, in an all-cash deal worth up to $850M. Headquartered ...

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million ...

Solventum has entered into an agreement to acquire Acera Surgical, a developer of materials for regenerative wound care, for $850 million. The deal will include an upfront cash payment of $725 million ...

President and Chief Executive Officer — Bryan C. Hanson Chief Financial Officer — Wayde D. McMillan Head of Investor Relations — Amy Wakeham Management stated the company is actively evaluating ...

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported third-quarter net income of $1.27 billion. On a per-share basis, the Maplewood, Minnesota-based company said ...

Shares of Solventum Corp. SOLV slipped 1.47% to $70.92 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.23% to 6,890.89 ...

The newly public Solventum Corp., the spinoff of 3M’s health care business, has raised its full-year financial guidance as its leaders work to establish a road map for the organization going forward.